If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Benzinga and Yahoo Finance LLC whitethorn gain committee oregon gross connected immoderate items done the links below.

Pfizer Inc. (NYSE:PFE) is simply a planetary biopharmaceutical institution that discovers, develops, manufactures, and markets medicines, vaccines, and healthcare products.

It is acceptable to study its Q4 2025 net connected Feb. 3. Wall Street analysts expect the institution to station EPS of $0.61, down from $0.63 successful the prior-year period. According to Benzinga Pro, quarterly gross is expected to scope $17.67 billion, down from $17.76 cardinal a twelvemonth earlier.

Don't Miss:

• Fast Company Calls It a ‘Groundbreaking Step for the Creator Economy' — Investors Can Still Get In astatine $0.85/Share

• Earn While You Scroll: The Deloitte-Ranked #1 Software Company Growing 32,481% Is Opening Its $0.50/Share Round to Accredited Investors.

The company's banal traded astatine astir $31.11 per stock 10 years ago. If you had invested $10,000, you could person bought astir 321 shares. Currently, shares commercialized astatine $25.71, meaning your investment's worth could person declined to $8,264 from banal terms depreciation. However, Pfizer besides paid dividends during these 10 years.

Pfizer's dividend output is presently 6.69%. Over the past 10 years, it has paid astir $15.70 successful dividends per share, which means you could person made $5,047 from dividends alone.

Summing up $8,264 and $5,047, we extremity up with the last worth of your investment, which is $13,311. This is however overmuch you could person made if you had invested $10,000 successful Pfizer banal 10 years ago. This means a full instrumentality of 33.11%. However, this fig is importantly little than the S&P 500 full instrumentality for the aforesaid period, which was 287.90%.

Trending: An EA Co-Founder Shapes This VC Backed Marketplace—Now You Can Invest successful Gaming's Next Big Platform

Pfizer has a statement standing of "Neutral" and a terms people of $33.35 based connected the ratings of 24 analysts. The terms people implies much than 29% imaginable upside from the existent banal price.

The institution connected Nov. 4 announced its Q3 2025 earnings, posting adjusted EPS of $0.87, compared to the statement estimation of $0.63, and revenues of $16.65 billion, compared to the statement of $16.59 billion, arsenic reported by Benzinga.

Pfizer raised its full-year 2025 adjusted EPS guidance to the scope of $3 to $3.15, versus statement estimation of $3.04. The U.S. cause elephantine reaffirmed its full-year gross guidance of $61 cardinal to $64 billion, compared to the statement of $62.88 billion.